Stanley Laman Group, Ltd. Amgen Inc Transaction History

Stanley Laman Group, Ltd.

$648 Million
Q3 2024

A detailed history of Stanley Laman Group, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 10,973 shares of AMGN stock, worth $2.89 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

10,973

Previous 10,736 2.21%

Holding current value

$2.89 Million

Previous $3.35 Million 5.4%

% of portfolio

0.55%

Previous 0.53%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $73,323 - $79,959	237 Added 2.21%	10,973 $3.54 Million
Q2 2024 Jul 18, 2024	BUY	$262.75 - $319.31 $2.82 Million - $3.43 Million	10,736 New	10,736 $3.35 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $5,999 - $7,094	28 Added 3.09%	935 $207,000
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $204,791 - $249,606	907 New	907 $219,000
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $1.59 Million - $1.76 Million	-6,793 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $39,499 - $46,030	178 Added 2.69%	6,793 $1.69 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $74,651 - $88,896	345 Added 5.5%	6,615 $1.52 Million
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $67,813 - $75,414	289 Added 4.83%	6,270 $1.59 Million
Q2 2020 Jul 20, 2020	BUY	$197.81 - $242.74 $105,037 - $128,894	531 Added 9.74%	5,981 $1.41 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $202,833 - $269,012	1,113 Added 25.66%	5,450 $1.11 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $13,812 - $17,753	-73 Reduced 1.66%	4,337 $1.05 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $109,166 - $130,804	-627 Reduced 12.45%	4,410 $853,000
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $14,002 - $16,414	84 Added 1.7%	5,037 $928,000
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $41,961 - $47,300	232 Added 4.91%	4,953 $941,000
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $28,900 - $33,736	162 Added 3.55%	4,721 $919,000
Q3 2018 Oct 30, 2018	BUY	$185.29 - $208.89 $5,929 - $6,684	32 Added 0.71%	4,559 $945,000
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $89,999 - $101,088	542 Added 13.6%	4,527 $836,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $51,845 - $60,588	306 Added 8.32%	3,985 $679,000
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $36,965 - $41,301	-219 Reduced 5.62%	3,679 $640,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $652,096 - $744,518	3,898	3,898 $727,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Account

Stanley Laman Group, Ltd. Amgen Inc Transaction History